Work

The vaginal microbiome associates with increased vaccine immune responses in the RV306 HIV vaccine trial in Thai women

Year: 2026
Type: preprint
Abstract: Background: The microbiome has been implicated in host immunity, but its relationship to vaccine-induced mucosal responses in the female genital tract is not well understood. Here we compared vaginal microbiome composition to host immunity and humoral immune responses to an HIV vaccine. Methods: Vaginal microbiome data was generated from participants receiving the RV144 ALVAC-HIV/AIDSVAX B/E prime/boost vaccine in the RV306 trial, and compared to mucosal and systemic immunity and binding antibody (bAb) levels at 2 weeks post-vaccine regimen. Results: Participants with Lactobacillus dominant microbiomes associated with increased mucosal and systemic bAb levels compared to non-Lactobacillus microbiomes. Pathways enriched in high vaccine responders and Lactobacillus dominant participants included increased mucosal innate immunity and systemic adaptive and B -cell responses, while non-Lactobacillus microbiomes associated with increased mucosal and systemic inflammatory phenotypes. Conclusion: These data suggest an association between increased innate immunity, Lactobacillus-dominant microbiome, and increased vaccine-induced bAb responses, which could inform improved interventional strategies.
Language: English
Subfield: Microbiology
Open Access status: green
OpenAlex ID: W7236716682
Cites:
Cited by:
Related to: 10